XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
Total
ATM Offering
Underwritten Public Offering
Common Stock
Common Stock
ATM Offering
Common Stock
Underwritten Public Offering
Additional Paid-In Capital
Additional Paid-In Capital
ATM Offering
Additional Paid-In Capital
Underwritten Public Offering
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at Dec. 31, 2017 $ (3,059,537)     $ 13,929     $ 131,492,595       $ (134,566,061)
Balance, shares at Dec. 31, 2017       13,929,763              
Exercise of stock options 40,504     $ 18     40,486        
Exercise of stock options, shares       18,028              
Stock-based compensation expense 1,143,188           1,143,188        
Release of restricted stock awards 270     $ 270              
Release of restricted stock awards, shares       269,551              
Net share settlement of restricted stock award (133,513)     $ (35)     (133,478)        
Net share settlement of restricted stock award, shares       (34,769)              
Employee stock purchase plan expense 14,453           14,453        
Issuance of common stock   $ 556,706 $ 37,724,316   $ 261 $ 13,915   $ 556,445 $ 37,710,401    
Issuance of common stock, shares         261,352 13,915,000          
Issuance of common stock warrants in connection with MidCapTerm Loan 74,000           74,000        
Net loss (5,379,947)                   (5,379,947)
Unrealized gain (loss) on short-term investments (11,151)                 $ (11,151)  
Balance at Mar. 31, 2018 30,969,289     $ 28,358     170,898,090     (11,151) (139,946,008)
Balance, shares at Mar. 31, 2018       28,358,925              
Balance at Dec. 31, 2017 $ (3,059,537)     $ 13,929     131,492,595       (134,566,061)
Balance, shares at Dec. 31, 2017       13,929,763              
Issuance of common stock, shares 5,733,314     261,352              
Net loss $ (9,482,676)                    
Unrealized gain (loss) on short-term investments (11,339)                    
Balance at Jun. 30, 2018 27,214,616     $ 28,414     171,246,278     (11,339) (144,048,737)
Balance, shares at Jun. 30, 2018       28,414,524              
Balance at Mar. 31, 2018 30,969,289     $ 28,358     170,898,090     (11,151) (139,946,008)
Balance, shares at Mar. 31, 2018       28,358,925              
Exercise of stock options 29,009     $ 16     28,993        
Exercise of stock options, shares       15,623              
Stock-based compensation expense 241,920           241,920        
Stock issued under stock purchase plans $ 77,315     $ 40     77,275        
Stock issued under stock purchase plans, shares       39,976              
Issuance of common stock, shares 5,733,314     261,352              
Net loss $ (4,102,729)                   (4,102,729)
Unrealized gain (loss) on short-term investments (188)                 (188)  
Balance at Jun. 30, 2018 27,214,616     $ 28,414     171,246,278     (11,339) (144,048,737)
Balance, shares at Jun. 30, 2018       28,414,524              
Balance at Dec. 31, 2018 21,092,062     $ 28,585     172,086,909     (3,453) (151,019,979)
Balance, shares at Dec. 31, 2018       28,585,449              
Exercise of stock options 51,570     $ 22     51,548        
Exercise of stock options, shares       21,871              
Stock-based compensation expense 241,233           241,233        
Release of restricted stock awards 13     $ 13              
Release of restricted stock awards, shares       13,126              
Net share settlement of restricted stock award (9,685)     $ (4)     (9,681)        
Net share settlement of restricted stock award, shares       (3,813)              
Employee stock purchase plan expense 16,794           16,794        
Net loss (5,370,846)                   (5,370,846)
Unrealized gain (loss) on short-term investments 3,353                 3,353  
Foreign currency translation adjustment 6,439                 6,439  
Balance at Mar. 31, 2019 16,030,933     $ 28,616     172,386,803     6,339 (156,390,825)
Balance, shares at Mar. 31, 2019       28,616,633              
Balance at Dec. 31, 2018 21,092,062     $ 28,585     172,086,909     (3,453) (151,019,979)
Balance, shares at Dec. 31, 2018       28,585,449              
Net loss (10,168,116)                    
Unrealized gain (loss) on short-term investments 4,172                    
Balance at Jun. 30, 2019 11,669,992     $ 28,707     172,831,416     (2,036) (161,188,095)
Balance, shares at Jun. 30, 2019       28,707,047              
Balance at Mar. 31, 2019 16,030,933     $ 28,616     172,386,803     6,339 (156,390,825)
Balance, shares at Mar. 31, 2019       28,616,633              
Exercise of stock options 69,384     $ 32     69,352        
Exercise of stock options, shares       32,385              
Stock-based compensation expense 287,317           287,317        
Release of restricted stock awards 15     $ 15              
Release of restricted stock awards, shares       15,001              
Net share settlement of restricted stock award (11,152)     $ (4)     (11,148)        
Net share settlement of restricted stock award, shares       (4,461)              
Stock issued under stock purchase plans 99,140     $ 48     99,092        
Stock issued under stock purchase plans, shares       47,489              
Net loss (4,797,270)                   (4,797,270)
Unrealized gain (loss) on short-term investments 819                 819  
Foreign currency translation adjustment (9,194)                 (9,194)  
Balance at Jun. 30, 2019 $ 11,669,992     $ 28,707     $ 172,831,416     $ (2,036) $ (161,188,095)
Balance, shares at Jun. 30, 2019       28,707,047